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Abstract: A catalytic enantioselective synthesis of heterocy-
clic vicinal fluoroamines is reported. A chiral Brønsted acid
promotes aza-Michael addition to fluoroalkenyl heterocycles
to give a prochiral enamine intermediate that undergoes
asymmetric protonation upon rearomatization. The reaction
accommodates a range of azaheterocycles and nucleophiles,
generating the CF stereocentre in high enantioselectivity,
and is also amenable to stereogenic CCF3 bonds. Extensive
DFT calculations provided evidence for stereocontrolled
proton transfer from catalyst to substrate as the rate-deter-
mining step, and showed the importance of steric interac-
tions from the catalyst’s alkyl groups in enforcing the high
enantioselectivity. Crystal structure data show the domi-
nance of noncovalent interactions in the core structure con-
formation, enabling modulation of the conformational land-
scape. Ramachandran-type analysis of conformer distribution
and Protein Data Bank mining indicated that benzylic fluori-
nation by this approach has the potential to improve the
potency of several marketed drugs.
Introduction
The incorporation of fluorine into organic compounds is prom-
inent in the pharmaceutical, agrochemical, and materials indus-
tries.[1] The unique characteristics of the CF bond enable
modulation of physicochemical properties while mitigating
steric contributions.[2] A key attribute is the intrinsic polarity of
the CF bond, which can induce conformational changes
through electrostatic and dipole interactions with neighbour-
ing functional groups. Installation of a chiral CF bond with a
vicinal relationship to a heteroatom or electron-withdrawing
group is particularly valuable, as exploitation of the gauche
effect allows predictable conformational control.[3] For exam-
ple, fluorinated phenethylamines are especially valuable given
the demonstrable utility of this compound class within bioac-
tive molecules,[4] and the topological control afforded by the
gauche effect can enable bespoke biological target engage-
ment.[5] Similarly, fluorine is often considered as a minimal
change to block metabolism, for example of labile benzyl posi-
tions.[2, 6] Given the stereoselective nature of most metabolic
processes, substitution of a specific CH for CF in a methyl-
ene represents a very efficient means of benefiting from this
effect, thus the introduction of fluorine in a stereoselective
fashion holds significant appeal.
Deoxyfluorination of alcohols is the most common method
to install C(sp3)F bonds, and numerous reagents have been
developed to facilitate this transformation (e.g. , Scheme 1a).[7, 8]
A noted problem with the introduction of a benzyl fluoride by
deoxyfluorination is the propensity for stereochemical erosion
due to variable contribution of SN1 pathways (e.g. , Scheme 1
b).[8a,9] This can be ameliorated in some cases by altering the
deoxyfluorination reagent in situ by using specific additives;
however, this general problem arises specifically from the nu-
cleophilic fluorinating reagents commonly used. An alternative
strategy for C(sp3)F bond formation that avoids SN2 is by
asymmetric protonation of prochiral C(sp2)F centres; however,
there are limited examples of this and none for benzylic
C(sp3)F.[10]
Herein, we present a method for the enantioselective syn-
thesis of benzylic C(sp3)F vicinal fluoroamines by asymmetric
protonation of in situ-generated prochiral fluoroenamines
(Scheme 1c).[10–12] This method allows the formation of a new
CN bond and a benzylic stereogenic CF bond in a single
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catalytic reaction, thereby providing direct modular access to
chiral heterocyclic vicinal fluoroamines from readily accessible
vinyl fluoride precursors.[13] As the process does not rely upon
the use of a fluorinating reagent, the issue of stereochemical
erosion is avoided. The mechanism is fully investigated, with
refinement of previous proposals, and we also show how the
relationship of the azaheterocycle, amine, and CF bonds pro-
vides unique conformational control, which could offer bene-
fits in drug design by better alignment with bound ligand con-
formation.
Results and Discussion
Method development
We have previously shown that Brønsted acid catalysis enables
conjugate addition and highly selective asymmetric proton-
ation of prochiral enamines (Scheme 2a).[14] However, this was
only amenable with the steric control of enamine geometry af-
forded by aryl substituents at the a-carbon: alkyl substituents
led to poor geometry control of the intermediate enamine 3,
resulting in lower enantioinduction in product 4. Although
fluorine has a small steric footprint, we postulated that dipole
minimization might provide an alternative selectivity determi-
nant (Scheme 2b). Indeed, preliminary DFT studies highlighted
the preferred s-trans geometry for benchmark starting material
5a, which was anticipated to assist geometrical control of the
developing fluoroenamine 6 and enhancing enantioinduction
in 7.
Based on this hypothesis, a benchmark process was estab-
lished whereby 5a was subjected to aniline (8), and Brønsted
acid catalyst 9a (Table 1; a range of catalysts were evaluated,
vide infra and see the Supporting Information). Optimization
of reaction parameters delivered a system that afforded the
desired product 7a in high conversion and enantioselectivity
(82% and 96:4 er ; entry 1). Several observations relating to op-
timization were noted (see the Supporting Information for full
details and additional experiments). Ethereal solvents (THF,
CPME) were particularly effective (entries 1 and 2), with other
solvents affording good to excellent conversion but with nota-
bly poorer enantioselectivity (entries 3 and 4). Lowering the re-
action temperature from 10 to 20 8C had little effect on
enantioselectivity but impacted reaction efficiency (entry 5). A
similar effect was observed by lowering catalyst loading, where
10 mol% was less efficient but maintained selectivity (entry 6).
Control experiments supported a catalyst-promoted reaction
that lacked background reactivity (entry 7).
The scope of the reaction was investigated (Scheme 3). A
range of aryl amine nucleophiles was accommodated with var-
iation in functional group (e.g. , halides, alkyl groups, BPin, het-
erocycles) and regiochemical substitution (ortho, meta, para)
was typically accommodated while maintaining selectivity
(Scheme 3a). Additionally, substitution on the aniline nitrogen
was tolerated (7m). It should be noted that the choice of sol-
vent was important for conversion, due to solubility: product
precipitation as the reaction progressed became problematic
for certain substrates ; however, changing ethereal solvent
based on substrate (THF or CPME) resolved this issue.
Scheme 1. a) Deoxyfluorination and exemplar reagents. b) Enantioerosion
during deoxyfluorination of benzylic alcohols. c) This work. Chiral heterocy-
clic vicinal fluoroamines by asymmetric protonation.
Scheme 2. a) Our previous work and simplified mechanism indicating asym-
metric induction is a function of enamine geometry control. b) Preliminary
DFT conformational analysis suggesting high enamine diastereoselectivity.
Table 1. Reaction development.
Deviation from ‘standard conditions’ Yield [%] (er (R :S))[a]
1 None 82 (96:4)[b]
2 CPME 89 (95:5)[b]
3 PhMe 95 (89:11)
4 CH2Cl2 70 (75:25)
5 20 8C 40 (96:4)
6 10 mol% 9a, 20 8C 37 (95:5)
7 0 mol% 9a, 20 8C 0 (–)
[a] Determined by HPLC using an internal standard. [b] Isolated yield.
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A range of vinylheterocycles was also generally well accom-
modated (Scheme 3b). Variation in substitution of the bench-
mark 2-vinylquinoline was straightforward (7a, 7n–q) and the
reaction tolerated quinoxaline (7r), benzothiazole (7s), and
pyridine (7t), with the latter a significantly more challenging
substrate due to its higher dearomatization barrier, hence re-
quiring a high temperature for the reaction to proceed, which
negatively affects enantioinduction. Significantly, the reaction
also allows enantioselective formation of stereogenic CCF3
bonds (11) ; however, catalyst loading had to be increased and
reaction temperature decreased to overcome a significant non-
selective background reaction observed for this substrate (see
the Supporting Information).
Mechanistic analysis
Two main mechanistic pathways are possible for the key asym-
metric protonation event (Scheme 4). The initial events
common to both pathways involve reversible protonation of
the substrate (5a) by the catalyst to provide LUMO-lowered in-
termediate complex 12 and enabling reversible aza-Michael
using PhNH2 (8) to deliver key intermediate 13. Two mechanis-
tic pathways are then possible from this intermediate: path-
way 1 proceeds via direct stereocontrolled proton transfer
from the anilinium via TS1 and delivers the product-catalyst
complex 15, which subsequently liberates the product (7a). Al-
ternatively, in pathway 2 proton transfer from the anilinium of
13 to the phosphate (via TS2) delivers 14, which undergoes
stereocontrolled proton transfer via TS3 to deliver 15. In our
previous report,[14] computational analysis supported pathway
1, with selectivity arising from good shape and electrostatic
complementarity between the catalyst and TS1 leading to the
observed enantiomer. These purely quantum mechanical stud-
ies did not yield transition states that would have supported
pathway 2 (or other alternative mechanisms). A series of kinetic
isotope effect experiments were conducted via the use of 15N-
aniline and PhND2. However, these proved inconclusive, with
independent rate experiments (see the Supporting Informa-
tion) resulting in observed 14/15N KIE of approximately 0.8 and
H/D KIE of approximately 1.8, which might be affected by the
pre-RDS equilibrium associated with this reaction.
Goodman and others have shown that catalysis by BINOL-
derived catalysts, such as 9a, can be studied effectively and ef-
ficiently by QM/MM ONIOM calculations where the quantum
mechanical aspects are described by B3LYP/6-31G** and the
molecular mechanics by UFF.[15] Accordingly, a more exhaustive
theoretical exploration was undertaken using this approach
(Figure 1 and Supporting Information).
Experimentally, no background reaction was observed,
which was consistent with DFT calculations that indicated a
Scheme 3. Substrate scope and isolated yields. Enantiomeric ratios deter-
mined by HPLC analysis on a chiral stationary phase. See the Supporting In-
formation for details. [a] CPME, 20 8C, 5 d. [b] 20 8C, 5 d. [c] CPME, 10 8C.
[d] CPME, RT. [e] 1 equiv of 9a, CPME, 50 8C.
Scheme 4. Proposed mechanistic pathways. Pathway 1: direct proton trans-
fer from anilinium to a prochiral centre. Pathway 2: proton transfer to/from
phosphate. RDS= rate determining step; TS= transition state.
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prohibitively high barrier for direct reaction of 5a with 8 (see
the Supporting Information).
Complexation of 5a with 9a to give 12 is moderately fa-
vourable, with the preferred dipole-induced s-trans conforma-
tion of 5a also retained in 12. This initial complex is held to-
gether by a H-bond (OH···N=1.63 ) and a weak peri CH···O=P
interaction (2.40 ). Complex 12 then undergoes dearomatiz-
ing aza-Michael addition to deliver 13, where the loss of aro-
maticity is compensated for by the formation of a tightly
bound ionic interaction between the anilinium NH and phos-
phate (P=O···HNHPH=1.38  and P=O···HNquin=1.71 ). Rear-
rangement within this complex by proton transfer from the
anilinium to the phosphate involves a low barrier and yields a
complex of the enamine (14) that is higher in energy than re-
actants. All of these steps are therefore strongly reversible and
no significant concentration of any of the intermediates subse-
quent to quinoline complexation would be expected—this
was confirmed by parallel NMR experiments (see the Support-
ing Information).
Transition states leading to each low-energy conformation
of complex 15-(R) and 15-(S) were optimized leading to an
array of conformations for each of TS1 and TS3. Consistent
with our previous report,[14] pathway 1, direct proton transfer
to the prochiral centre was identified (TS1). This process has a
significant barrier (+35 kcalmol1) but is predicted to be
highly stereoselective (DDG=4.4 kcalmol1, >99:1 er) in
favour of the experimentally observed enantiomer. Although
this rationalizes the stereoselectivity of the process, it is not
consistent with the experimental rate of reaction.
However, pathway 2 was more consistent with the experi-
mentally observed rate. The key step, in which the stereo-
chemistry is generated, involves protonation of the enamine
by the POH in complex 14 via TS3 and exhibits a clear prefer-
ence for the experimentally observed enantiomer (DDG =
+3.5 kcalmol1), which arises from geometrical restrictions be-
tween the catalyst and enamine in the developing transition
states TS3-(R) and TS3-(S) (vide infra). The iPr substituents of
catalyst 9a are also particularly important for imposing this
geometrical restriction (vide infra: Table 2 and Figure 3, below).
This mechanistic overview reveals that the catalyst provides its
effect by acting as both acid and base at each stage as re-
quired and does so in a way that imposes specific shape re-
quirements on the substrate that interplay with the polar inter-
actions that hold the complex together.
Figure 1. Free-energy profile comparison [ONIOM (B3LYP/6-31G**:UFF; single-point energy M06-2X/6-31G**(+PCM for Et2O)] . Two pathways are compared:
Pathway 1: direct proton transfer and pathway 2: proton transfer to and from the phosphate. Free energies in kcalmol1 are reported relative to separated
substrate and catalyst bound to THF. All calculations were performed in Gaussian09, and free energies at 20 8C and 1m concentration were obtained by
using goodvibes.[16]
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Based on these results, a complete reinvestigation of the
computational analysis of our previous process using aryl sub-
stituents (Scheme 2a)[14] using the approach delineated above
suggests that Pathway 2 is a more likely reaction mechanism
in this process. The full profile for this reaction is provided in
the Supporting Information.
Control substrates 7u–7w provided additional support of
the DFT conclusions (Figure 2).
Despite moderate yields of product for each, enantioinduc-
tion was poor, which arises from features that are not well-tol-
erated in the lowest energy transition state. Substrate 7u
places the fused phenyl ring in a position that clashes with the
iPr groups of 9a in TS3. In contrast, 7v prevents the required
simultaneous interactions of 5a and 8 with 9a and also lacks
the dipole-induced geometry control. Lastly, the essential en-
amine NH-OP H-bond in TS3 is impaired by the adjacent chlo-
rine in substrate 7w, weakening the association between the
substrate and catalyst.
With regards to the optimal catalyst, a catalyst survey dem-
onstrated the superior level of asymmetric induction using 9a
(Table 2; see the Supporting Information for full details). To de-
termine the origin of this enhanced selectivity, we analysed 9a
in comparison to the related 3,3’-mesityl (9b) and -phenyl (9c)
analogues (Figure 3). As the stereodirecting group on the cata-
lyst is reduced in size from 9a to 9b and 9c, there is a general
tendency for the barrier for the catalysed reaction to increase
(from 16.2 to 16.6 and 18.5 kcalmol1, respectively), resulting
in the observed diminished conversion. This is accompanied
by a sharp erosion in DDG between TS3-(R) and TS3-(S)—the
energy associated with TS3-(R) remains similar for all three,
and this erosion is principally driven by a change in energy of
TS3-(S). This is highlighted in the preferred conformation of
each of the three structures equivalent to TS3-(S) (Figure 3).
The red arrows (Figure 3a) indicate where the bulk of the iPr
groups of 9a press against both ends of the bound substrate.
This causes the break-up of an intramolecular H-bond between
the aniline nitrogen and the NH of the nitrogen arising from
the quinoline (2.48  for 9a, but 2.02 and 2.03  for 9b and
9c, respectively) ; this interchanges with an interaction be-
tween the aniline NH and a phosphate oxygen (2.01  for 9a,
but 2.69 and 2.67  for 9b and 9c, respectively). The combina-
tion of the steric clashing and this change in hydrogen bond-
ing pattern clearly disfavours TS3-(S) compared to TS3-(R) for
9a ; this difference is significantly reduced for 9b and 9c.
In line with experimental observations, the computational
model also confirms a lower rate of catalysed reaction for 5t,
associated with the larger dearomatization barrier (see the
Supporting Information). The observed significant background
reaction for 10 was also investigated computationally, confirm-
ing the accelerating role of the LUMO-lowering CF3 unit as pre-
viously observed for other Michael acceptors.[17]
Implications for conformational control
The value of the substructures accessible using the developed
protocol was explored by investigating their conformational
properties. The crystal structure of 7a shows an anti relation-
ship between CF and the aniline nitrogen (dihedral angle=
1798), which is likely preferred in comparison to the gauche
due to a favourable Npz···s*C-F interaction (Figure 4). The CF
bond is almost perpendicular to the carbon framework of the
quinoline (dihedral angle=1078), which we believe arises due
to a favourable s*C-F···pAr interaction competing with CF/Nquin
dipole minimization.[18] Hydrogen bonding of the quinoline ni-
trogen with a hydrogen bond donor would reduce this dipole
and is a key feature of this system: the crystal structure has an
intermolecular hydrogen bond between the quinoline nitrogen
and the HNPh in an adjacent molecule.
To reduce the impact of hydrogen bonding and any Npz in-
teractions, 7a was acetylated to give 16 (Figure 4a). The pref-
erence towards the anti configuration is diminished, with the
gauche conformation noted in the crystal structure (FCCNAniline
dihedral angle=588). The dihedral angle between the CF
bond and quinoline nitrogen is 1748, explicitly affected by the
CF/NAr dipole minimization and no longer modulated by the
other effects described.
Ramachandran plots for dihedral angles 1 and 2 of 7a, 16,
and the parent 2-pyridylethylamine (not shown) were comput-
ed and reveal that the introduction of the benzylic fluoride has
Table 2. Catalyst structure vs. enantioselectivity.
Catalyst R Yield [%] (er (R :S))[a]
1 9a 2,4,6-(i-Pr)3C6H2 40 (96:4)
2 9b 2,4,6-(Me)3C6H2 25 (88:12)
3 9c Ph 11 (58:42)
[a] Determined by HPLC using an internal standard.
Figure 2. Control substrates. Reaction conditions as per Scheme 3 unless
noted. [a] CPME. [b] CPME, RT. [c] CPME, 40 8C.
Figure 3. Structures equivalent to TS3-(S) for catalysts 9a, 9b, and 9c.
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a profound effect on the overall conformational landscape
(Figure 4 and Supporting Information). Compounds 7a and 16
display specific low-energy conformations biased by the pres-
ence of the fluorine and that are likely to be populated in solu-
tion. This presents opportunities for application in drug discov-
ery by improving binding affinity and selectivity by decreasing
the population of alternative, less favourable conformations.
The protein databank was searched for ligands that contain
the 2-pyridylethylamine substructure and the conformations
that are populated in these crystal structures are mapped onto
the Ramachandran plot for 7a (Figure 4b, black dots). Five
compounds in particular adopt a conformation that would be
enhanced by the introduction of fluorine at the benzylic posi-
tion (Figure 4b, circled), including inhibitors of HIV reverse
transcriptase,[19] cathepsin L,[20] and purine nucleoside phos-
phorylases (Figure 4c).[21] This highlights the value of this struc-
tural change for enhancing potency and selectivity of potential
drug molecules.
Conclusions
In summary, a Brønsted acid-catalysed aza-Michael/asymmetric
protonation method for the synthesis of heterocyclic vicinal
fluoroamines has been developed. The method allows access
to stereogenic CF bonds in high selectivity and on a selection
of different heterocyclic templates. The method also translates
to establishing stereogenic CF3 analogues. The origin of the re-
activity and stereoinduction has been investigated by extend-
ed DFT calculations that have established a phosphate proton
transfer as being more consistent with experimental observa-
tions than a direct proton-transfer process. This has led to a re-
vision of our interpretation of the mechanism associated with
our previous report. Conformational control of the vicinal phe-
nethylamine system has been interrogated by DFT and crystal-
lography, identifying the likely preferred topologies in the solid
and solution state. This might have strategic applications in
drug discovery by introducing conformational bias to access
conformations more like the bound state, illustrated with ex-
amples extracted from the PDB.[22]
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Chiral Brønsted acid catalysis enables
the synthesis of heterocyclic vicinal fluo-
roamines by asymmetric protonation.
The reaction accommodates a range of
azaheterocycles and nucleophiles, gen-
erating the CF stereocentre in high
enantioselectivity, and allows the forma-
tion of chiral CCF3 bonds. DFT calcula-
tions provided insight into the reaction
mechanism, and conformational control
of the products is elucidated.
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